Thick Layer Resists
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Cellular Human Tissue-engineered Skin Substitute Market Research Report 2023
1 Cellular Human Tissue-engineered Skin Substitute Market Overview
1.1 Product Overview and Scope of Cellular Human Tissue-engineered Skin Substitute
1.2 Cellular Human Tissue-engineered Skin Substitute Segment by Type
1.2.1 Global Cellular Human Tissue-engineered Skin Substitute Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Cellular Allogeneic
1.2.3 Cellular Autologous
1.2.4 Others
1.3 Cellular Human Tissue-engineered Skin Substitute Segment by Application
1.3.1 Global Cellular Human Tissue-engineered Skin Substitute Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Wound Care Centers
1.4 Global Cellular Human Tissue-engineered Skin Substitute Market Size Estimates and Forecasts
1.4.1 Global Cellular Human Tissue-engineered Skin Substitute Revenue 2017-2028
1.4.2 Global Cellular Human Tissue-engineered Skin Substitute Sales 2017-2028
1.4.3 Cellular Human Tissue-engineered Skin Substitute Market Size by Region: 2017 Versus 2021 Versus 2028
2 Cellular Human Tissue-engineered Skin Substitute Market Competition by Manufacturers
2.1 Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Manufacturers (2017-2022)
2.2 Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Cellular Human Tissue-engineered Skin Substitute Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Cellular Human Tissue-engineered Skin Substitute Manufacturing Sites, Area Served, Product Type
2.5 Cellular Human Tissue-engineered Skin Substitute Market Competitive Situation and Trends
2.5.1 Cellular Human Tissue-engineered Skin Substitute Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Cellular Human Tissue-engineered Skin Substitute Players Market Share by Revenue
2.5.3 Global Cellular Human Tissue-engineered Skin Substitute Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cellular Human Tissue-engineered Skin Substitute Retrospective Market Scenario by Region
3.1 Global Cellular Human Tissue-engineered Skin Substitute Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Cellular Human Tissue-engineered Skin Substitute Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Cellular Human Tissue-engineered Skin Substitute Market Facts & Figures by Country
3.3.1 North America Cellular Human Tissue-engineered Skin Substitute Sales by Country
3.3.2 North America Cellular Human Tissue-engineered Skin Substitute Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Cellular Human Tissue-engineered Skin Substitute Market Facts & Figures by Country
3.4.1 Europe Cellular Human Tissue-engineered Skin Substitute Sales by Country
3.4.2 Europe Cellular Human Tissue-engineered Skin Substitute Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cellular Human Tissue-engineered Skin Substitute Market Facts & Figures by Region
3.5.1 Asia Pacific Cellular Human Tissue-engineered Skin Substitute Sales by Region
3.5.2 Asia Pacific Cellular Human Tissue-engineered Skin Substitute Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Cellular Human Tissue-engineered Skin Substitute Market Facts & Figures by Country
3.6.1 Latin America Cellular Human Tissue-engineered Skin Substitute Sales by Country
3.6.2 Latin America Cellular Human Tissue-engineered Skin Substitute Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Cellular Human Tissue-engineered Skin Substitute Market Facts & Figures by Country
3.7.1 Middle East and Africa Cellular Human Tissue-engineered Skin Substitute Sales by Country
3.7.2 Middle East and Africa Cellular Human Tissue-engineered Skin Substitute Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Cellular Human Tissue-engineered Skin Substitute Historic Market Analysis by Type
4.1 Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Type (2017-2022)
4.2 Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Type (2017-2022)
4.3 Global Cellular Human Tissue-engineered Skin Substitute Price by Type (2017-2022)
5 Global Cellular Human Tissue-engineered Skin Substitute Historic Market Analysis by Application
5.1 Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Application (2017-2022)
5.2 Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Application (2017-2022)
5.3 Global Cellular Human Tissue-engineered Skin Substitute Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Allergan (AbbVie)
6.1.1 Allergan (AbbVie) Corporation Information
6.1.2 Allergan (AbbVie) Description and Business Overview
6.1.3 Allergan (AbbVie) Cellular Human Tissue-engineered Skin Substitute Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Allergan (AbbVie) Cellular Human Tissue-engineered Skin Substitute Product Portfolio
6.1.5 Allergan (AbbVie) Recent Developments/Updates
6.2 AlloSource
6.2.1 AlloSource Corporation Information
6.2.2 AlloSource Description and Business Overview
6.2.3 AlloSource Cellular Human Tissue-engineered Skin Substitute Sales, Revenue and Gross Margin (2017-2022)
6.2.4 AlloSource Cellular Human Tissue-engineered Skin Substitute Product Portfolio
6.2.5 AlloSource Recent Developments/Updates
6.3 Organogenesis
6.3.1 Organogenesis Corporation Information
6.3.2 Organogenesis Description and Business Overview
6.3.3 Organogenesis Cellular Human Tissue-engineered Skin Substitute Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Organogenesis Cellular Human Tissue-engineered Skin Substitute Product Portfolio
6.3.5 Organogenesis Recent Developments/Updates
6.4 BD
6.4.1 BD Corporation Information
6.4.2 BD Description and Business Overview
6.4.3 BD Cellular Human Tissue-engineered Skin Substitute Sales, Revenue and Gross Margin (2017-2022)
6.4.4 BD Cellular Human Tissue-engineered Skin Substitute Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Smith & Nephew
6.5.1 Smith & Nephew Corporation Information
6.5.2 Smith & Nephew Description and Business Overview
6.5.3 Smith & Nephew Cellular Human Tissue-engineered Skin Substitute Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Smith & Nephew Cellular Human Tissue-engineered Skin Substitute Product Portfolio
6.5.5 Smith & Nephew Recent Developments/Updates
6.6 Integra LifeSciences
6.6.1 Integra LifeSciences Corporation Information
6.6.2 Integra LifeSciences Description and Business Overview
6.6.3 Integra LifeSciences Cellular Human Tissue-engineered Skin Substitute Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Integra LifeSciences Cellular Human Tissue-engineered Skin Substitute Product Portfolio
6.6.5 Integra LifeSciences Recent Developments/Updates
6.7 Synthes (Johnson & Johnson)
6.6.1 Synthes (Johnson & Johnson) Corporation Information
6.6.2 Synthes (Johnson & Johnson) Description and Business Overview
6.6.3 Synthes (Johnson & Johnson) Cellular Human Tissue-engineered Skin Substitute Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Synthes (Johnson & Johnson) Cellular Human Tissue-engineered Skin Substitute Product Portfolio
6.7.5 Synthes (Johnson & Johnson) Recent Developments/Updates
6.8 Axogen
6.8.1 Axogen Corporation Information
6.8.2 Axogen Description and Business Overview
6.8.3 Axogen Cellular Human Tissue-engineered Skin Substitute Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Axogen Cellular Human Tissue-engineered Skin Substitute Product Portfolio
6.8.5 Axogen Recent Developments/Updates
6.9 Vericel Corporation
6.9.1 Vericel Corporation Corporation Information
6.9.2 Vericel Corporation Description and Business Overview
6.9.3 Vericel Corporation Cellular Human Tissue-engineered Skin Substitute Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Vericel Corporation Cellular Human Tissue-engineered Skin Substitute Product Portfolio
6.9.5 Vericel Corporation Recent Developments/Updates
6.10 LifeNet Health
6.10.1 LifeNet Health Corporation Information
6.10.2 LifeNet Health Description and Business Overview
6.10.3 LifeNet Health Cellular Human Tissue-engineered Skin Substitute Sales, Revenue and Gross Margin (2017-2022)
6.10.4 LifeNet Health Cellular Human Tissue-engineered Skin Substitute Product Portfolio
6.10.5 LifeNet Health Recent Developments/Updates
6.11 MTF Biologics
6.11.1 MTF Biologics Corporation Information
6.11.2 MTF Biologics Cellular Human Tissue-engineered Skin Substitute Description and Business Overview
6.11.3 MTF Biologics Cellular Human Tissue-engineered Skin Substitute Sales, Revenue and Gross Margin (2017-2022)
6.11.4 MTF Biologics Cellular Human Tissue-engineered Skin Substitute Product Portfolio
6.11.5 MTF Biologics Recent Developments/Updates
6.12 Arthrex
6.12.1 Arthrex Corporation Information
6.12.2 Arthrex Cellular Human Tissue-engineered Skin Substitute Description and Business Overview
6.12.3 Arthrex Cellular Human Tissue-engineered Skin Substitute Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Arthrex Cellular Human Tissue-engineered Skin Substitute Product Portfolio
6.12.5 Arthrex Recent Developments/Updates
6.13 Wright Medical Group NV (Stryker)
6.13.1 Wright Medical Group NV (Stryker) Corporation Information
6.13.2 Wright Medical Group NV (Stryker) Cellular Human Tissue-engineered Skin Substitute Description and Business Overview
6.13.3 Wright Medical Group NV (Stryker) Cellular Human Tissue-engineered Skin Substitute Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Wright Medical Group NV (Stryker) Cellular Human Tissue-engineered Skin Substitute Product Portfolio
6.13.5 Wright Medical Group NV (Stryker) Recent Developments/Updates
6.14 Cook Biotech Incorporated
6.14.1 Cook Biotech Incorporated Corporation Information
6.14.2 Cook Biotech Incorporated Cellular Human Tissue-engineered Skin Substitute Description and Business Overview
6.14.3 Cook Biotech Incorporated Cellular Human Tissue-engineered Skin Substitute Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Cook Biotech Incorporated Cellular Human Tissue-engineered Skin Substitute Product Portfolio
6.14.5 Cook Biotech Incorporated Recent Developments/Updates
6.15 Aroa Biosurgery
6.15.1 Aroa Biosurgery Corporation Information
6.15.2 Aroa Biosurgery Cellular Human Tissue-engineered Skin Substitute Description and Business Overview
6.15.3 Aroa Biosurgery Cellular Human Tissue-engineered Skin Substitute Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Aroa Biosurgery Cellular Human Tissue-engineered Skin Substitute Product Portfolio
6.15.5 Aroa Biosurgery Recent Developments/Updates
6.16 Surgalign Holdings
6.16.1 Surgalign Holdings Corporation Information
6.16.2 Surgalign Holdings Cellular Human Tissue-engineered Skin Substitute Description and Business Overview
6.16.3 Surgalign Holdings Cellular Human Tissue-engineered Skin Substitute Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Surgalign Holdings Cellular Human Tissue-engineered Skin Substitute Product Portfolio
6.16.5 Surgalign Holdings Recent Developments/Updates
7 Cellular Human Tissue-engineered Skin Substitute Manufacturing Cost Analysis
7.1 Cellular Human Tissue-engineered Skin Substitute Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cellular Human Tissue-engineered Skin Substitute
7.4 Cellular Human Tissue-engineered Skin Substitute Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cellular Human Tissue-engineered Skin Substitute Distributors List
8.3 Cellular Human Tissue-engineered Skin Substitute Customers
9 Cellular Human Tissue-engineered Skin Substitute Market Dynamics
9.1 Cellular Human Tissue-engineered Skin Substitute Industry Trends
9.2 Cellular Human Tissue-engineered Skin Substitute Market Drivers
9.3 Cellular Human Tissue-engineered Skin Substitute Market Challenges
9.4 Cellular Human Tissue-engineered Skin Substitute Market Restraints
10 Global Market Forecast
10.1 Cellular Human Tissue-engineered Skin Substitute Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cellular Human Tissue-engineered Skin Substitute by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Cellular Human Tissue-engineered Skin Substitute by Type (2023-2028)
10.2 Cellular Human Tissue-engineered Skin Substitute Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cellular Human Tissue-engineered Skin Substitute by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Cellular Human Tissue-engineered Skin Substitute by Application (2023-2028)
10.3 Cellular Human Tissue-engineered Skin Substitute Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cellular Human Tissue-engineered Skin Substitute by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Cellular Human Tissue-engineered Skin Substitute by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Cellular Human Tissue-engineered Skin Substitute Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Cellular Human Tissue-engineered Skin Substitute Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Cellular Human Tissue-engineered Skin Substitute Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Cellular Human Tissue-engineered Skin Substitute Market Competitive Situation by Manufacturers in 2021
Table 5. Global Cellular Human Tissue-engineered Skin Substitute Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Cellular Human Tissue-engineered Skin Substitute Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Cellular Human Tissue-engineered Skin Substitute Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Cellular Human Tissue-engineered Skin Substitute Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Cellular Human Tissue-engineered Skin Substitute Manufacturing Sites and Area Served
Table 11. Manufacturers Cellular Human Tissue-engineered Skin Substitute Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Cellular Human Tissue-engineered Skin Substitute by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cellular Human Tissue-engineered Skin Substitute as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Cellular Human Tissue-engineered Skin Substitute Sales by Region (2017-2022) & (K Units)
Table 16. Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Region (2017-2022)
Table 17. Global Cellular Human Tissue-engineered Skin Substitute Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Region (2017-2022)
Table 19. North America Cellular Human Tissue-engineered Skin Substitute Sales by Country (2017-2022) & (K Units)
Table 20. North America Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Country (2017-2022)
Table 21. North America Cellular Human Tissue-engineered Skin Substitute Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Country (2017-2022)
Table 23. Europe Cellular Human Tissue-engineered Skin Substitute Sales by Country (2017-2022) & (K Units)
Table 24. Europe Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Country (2017-2022)
Table 25. Europe Cellular Human Tissue-engineered Skin Substitute Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Cellular Human Tissue-engineered Skin Substitute Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Cellular Human Tissue-engineered Skin Substitute Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Region (2017-2022)
Table 31. Latin America Cellular Human Tissue-engineered Skin Substitute Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Country (2017-2022)
Table 33. Latin America Cellular Human Tissue-engineered Skin Substitute Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Cellular Human Tissue-engineered Skin Substitute Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Cellular Human Tissue-engineered Skin Substitute Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Country (2017-2022)
Table 39. Global Cellular Human Tissue-engineered Skin Substitute Sales by Type (2017-2022) & (K Units)
Table 40. Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Type (2017-2022)
Table 41. Global Cellular Human Tissue-engineered Skin Substitute Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Cellular Human Tissue-engineered Skin Substitute Revenue Share by Type (2017-2022)
Table 43. Global Cellular Human Tissue-engineered Skin Substitute Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Cellular Human Tissue-engineered Skin Substitute Sales (K Units) by Application (2017-2022)
Table 45. Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Application (2017-2022)
Table 46. Global Cellular Human Tissue-engineered Skin Substitute Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Cellular Human Tissue-engineered Skin Substitute Revenue Share by Application (2017-2022)
Table 48. Global Cellular Human Tissue-engineered Skin Substitute Price by Application (2017-2022) & (US$/Unit)
Table 49. Allergan (AbbVie) Corporation Information
Table 50. Allergan (AbbVie) Description and Business Overview
Table 51. Allergan (AbbVie) Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Allergan (AbbVie) Cellular Human Tissue-engineered Skin Substitute Product
Table 53. Allergan (AbbVie) Recent Developments/Updates
Table 54. AlloSource Corporation Information
Table 55. AlloSource Description and Business Overview
Table 56. AlloSource Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. AlloSource Cellular Human Tissue-engineered Skin Substitute Product
Table 58. AlloSource Recent Developments/Updates
Table 59. Organogenesis Corporation Information
Table 60. Organogenesis Description and Business Overview
Table 61. Organogenesis Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Organogenesis Cellular Human Tissue-engineered Skin Substitute Product
Table 63. Organogenesis Recent Developments/Updates
Table 64. BD Corporation Information
Table 65. BD Description and Business Overview
Table 66. BD Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. BD Cellular Human Tissue-engineered Skin Substitute Product
Table 68. BD Recent Developments/Updates
Table 69. Smith & Nephew Corporation Information
Table 70. Smith & Nephew Description and Business Overview
Table 71. Smith & Nephew Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Smith & Nephew Cellular Human Tissue-engineered Skin Substitute Product
Table 73. Smith & Nephew Recent Developments/Updates
Table 74. Integra LifeSciences Corporation Information
Table 75. Integra LifeSciences Description and Business Overview
Table 76. Integra LifeSciences Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Integra LifeSciences Cellular Human Tissue-engineered Skin Substitute Product
Table 78. Integra LifeSciences Recent Developments/Updates
Table 79. Synthes (Johnson & Johnson) Corporation Information
Table 80. Synthes (Johnson & Johnson) Description and Business Overview
Table 81. Synthes (Johnson & Johnson) Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Synthes (Johnson & Johnson) Cellular Human Tissue-engineered Skin Substitute Product
Table 83. Synthes (Johnson & Johnson) Recent Developments/Updates
Table 84. Axogen Corporation Information
Table 85. Axogen Description and Business Overview
Table 86. Axogen Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Axogen Cellular Human Tissue-engineered Skin Substitute Product
Table 88. Axogen Recent Developments/Updates
Table 89. Vericel Corporation Corporation Information
Table 90. Vericel Corporation Description and Business Overview
Table 91. Vericel Corporation Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Vericel Corporation Cellular Human Tissue-engineered Skin Substitute Product
Table 93. Vericel Corporation Recent Developments/Updates
Table 94. LifeNet Health Corporation Information
Table 95. LifeNet Health Description and Business Overview
Table 96. LifeNet Health Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. LifeNet Health Cellular Human Tissue-engineered Skin Substitute Product
Table 98. LifeNet Health Recent Developments/Updates
Table 99. MTF Biologics Corporation Information
Table 100. MTF Biologics Description and Business Overview
Table 101. MTF Biologics Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. MTF Biologics Cellular Human Tissue-engineered Skin Substitute Product
Table 103. MTF Biologics Recent Developments/Updates
Table 104. Arthrex Corporation Information
Table 105. Arthrex Description and Business Overview
Table 106. Arthrex Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Arthrex Cellular Human Tissue-engineered Skin Substitute Product
Table 108. Arthrex Recent Developments/Updates
Table 109. Wright Medical Group NV (Stryker) Corporation Information
Table 110. Wright Medical Group NV (Stryker) Description and Business Overview
Table 111. Wright Medical Group NV (Stryker) Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Wright Medical Group NV (Stryker) Cellular Human Tissue-engineered Skin Substitute Product
Table 113. Wright Medical Group NV (Stryker) Recent Developments/Updates
Table 114. Cook Biotech Incorporated Corporation Information
Table 115. Cook Biotech Incorporated Description and Business Overview
Table 116. Cook Biotech Incorporated Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Cook Biotech Incorporated Cellular Human Tissue-engineered Skin Substitute Product
Table 118. Cook Biotech Incorporated Recent Developments/Updates
Table 119. Aroa Biosurgery Corporation Information
Table 120. Aroa Biosurgery Description and Business Overview
Table 121. Aroa Biosurgery Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Aroa Biosurgery Cellular Human Tissue-engineered Skin Substitute Product
Table 123. Aroa Biosurgery Recent Developments/Updates
Table 124. Surgalign Holdings Corporation Information
Table 125. Surgalign Holdings Description and Business Overview
Table 126. Surgalign Holdings Cellular Human Tissue-engineered Skin Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Surgalign Holdings Cellular Human Tissue-engineered Skin Substitute Product
Table 128. Surgalign Holdings Recent Developments/Updates
Table 129. Production Base and Market Concentration Rate of Raw Material
Table 130. Key Suppliers of Raw Materials
Table 131. Cellular Human Tissue-engineered Skin Substitute Distributors List
Table 132. Cellular Human Tissue-engineered Skin Substitute Customers List
Table 133. Cellular Human Tissue-engineered Skin Substitute Market Trends
Table 134. Cellular Human Tissue-engineered Skin Substitute Market Drivers
Table 135. Cellular Human Tissue-engineered Skin Substitute Market Challenges
Table 136. Cellular Human Tissue-engineered Skin Substitute Market Restraints
Table 137. Global Cellular Human Tissue-engineered Skin Substitute Sales Forecast by Type (2023-2028) & (K Units)
Table 138. Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share Forecast by Type (2023-2028)
Table 139. Global Cellular Human Tissue-engineered Skin Substitute Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 140. Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share Forecast by Type (2023-2028)
Table 141. Global Cellular Human Tissue-engineered Skin Substitute Sales Forecast by Application (2023-2028) & (K Units)
Table 142. Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share Forecast by Application (2023-2028)
Table 143. Global Cellular Human Tissue-engineered Skin Substitute Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 144. Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share Forecast by Application (2023-2028)
Table 145. Global Cellular Human Tissue-engineered Skin Substitute Sales Forecast by Region (2023-2028) & (K Units)
Table 146. Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share Forecast by Region (2023-2028)
Table 147. Global Cellular Human Tissue-engineered Skin Substitute Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 148. Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share Forecast by Region (2023-2028)
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cellular Human Tissue-engineered Skin Substitute
Figure 2. Global Cellular Human Tissue-engineered Skin Substitute Market Share by Type in 2021 & 2028
Figure 3. Cellular Allogeneic Product Picture
Figure 4. Cellular Autologous Product Picture
Figure 5. Others Product Picture
Figure 6. Global Cellular Human Tissue-engineered Skin Substitute Market Share by Application in 2021 & 2028
Figure 7. Hospitals
Figure 8. Specialty Clinics
Figure 9. Wound Care Centers
Figure 10. Global Cellular Human Tissue-engineered Skin Substitute Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Cellular Human Tissue-engineered Skin Substitute Market Size (2017-2028) & (US$ Million)
Figure 12. Global Cellular Human Tissue-engineered Skin Substitute Sales (2017-2028) & (K Units)
Figure 13. Cellular Human Tissue-engineered Skin Substitute Sales Share by Manufacturers in 2021
Figure 14. Global Cellular Human Tissue-engineered Skin Substitute Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Cellular Human Tissue-engineered Skin Substitute Players: Market Share by Revenue in 2021
Figure 16. Cellular Human Tissue-engineered Skin Substitute Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Region (2017-2022)
Figure 18. Global Cellular Human Tissue-engineered Skin Substitute Sales Market Share by Region in 2021
Figure 19. Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Region (2017-2022)
Figure 20. Global Cellular Human Tissue-engineered Skin Substitute Revenue Market Share by Region in 2021
Figure 21. United States Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. China Taiwan Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Mexico Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Brazil Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Argentina Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Turkey Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Saudi Arabia Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. UAE Cellular Human Tissue-engineered Skin Substitute Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Sales Market Share of Cellular Human Tissue-engineered Skin Substitute by Type (2017-2022)
Figure 44. Manufacturing Cost Structure of Cellular Human Tissue-engineered Skin Substitute
Figure 45. Manufacturing Process Analysis of Cellular Human Tissue-engineered Skin Substitute
Figure 46. Cellular Human Tissue-engineered Skin Substitute Industrial Chain Analysis
Figure 47. Channels of Distribution
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Allergan (AbbVie) AlloSource Organogenesis BD Smith & Nephew Integra LifeSciences Synthes (Johnson & Johnson) Axogen Vericel Corporation LifeNet Health MTF Biologics Arthrex Wright Medical Group NV (Stryker) Cook Biotech Incorporated Aroa Biosurgery Surgalign Holdings